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Abstract
The peptide hormone gastrin is known to play a role in differentiation, growth and apoptosis of cells in the gastric
mucosa. In this study we demonstrate that gastrin induces Nuclear Receptor 4A2 (NR4A2) expression in the
adenocarcinoma cell lines AR42J and AGS-GR, which both possess the gastrin/CCK2 receptor. In vivo, NR4A2 is
strongly expressed in the gastrin responsive neuroendocrine ECL cells in normal mucosa, whereas gastric
adenocarcinoma tissue reveals a more diffuse and variable expression in tumor cells. We show that NR4A2 is a
primary early transient gastrin induced gene in adenocarcinoma cell lines, and that NR4A2 expression is negatively
regulated by inducible cAMP early repressor (ICER) and zinc finger protein 36, C3H1 type-like 1 (Zfp36l1),
suggesting that these gastrin regulated proteins exert a negative feedback control of NR4A2 activated responses.
FRAP analyses indicate that gastrin also modifies the nucleus-cytosol shuttling of NR4A2, with more NR4A2
localized to cytoplasm upon gastrin treatment. Knock-down experiments with siRNA targeting NR4A2 increase
migration of gastrin treated adenocarcinoma AGS-GR cells, while ectopically expressed NR4A2 increases apoptosis
and hampers gastrin induced invasion, indicating a tumor suppressor function of NR4A2. Collectively, our results
uncover a role of NR4A2 in gastric adenocarcinoma cells, and suggest that both the level and the localization of
NR4A2 protein are of importance regarding the cellular responses of these cells.
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Introduction
Gastrin is a gastrointestinal peptide hormone which plays a
central role in regulation of gastric acid secretion [1], and in
differentiation, maintenance and organization of cells/tissue in
the gastric mucosa [2,3]. Beside its role in regulation of normal
physiology, gastrin is shown to exert growth promoting impact
both in normal and malignant gastrointestinal tissue. Gastrin
stimulates proliferation of human gastric and pancreatic cell
lines [4-6]. Hypergastrinemia is associated with gastric
neuroendocrine tumors (carcinoids) [7] and is found to regulate
the expression of anti- and pro-apoptotic genes in both human
[8] and rat [9] mucosa. Gastrin mediates its effect via the
cholecystokinin-2 receptor (CCK2R), primarily expressed by
enterochromaffin-like (ECL) cells, but also reported to be
expressed in cancer like colorectal and pancreatic
adenocarcinomas [10-12].
The nuclear receptor 4A2 (NR4A2) is a member of the
Nurr77 orphan receptor subfamily that comprises NR4A1
(NGIF-B/Nur77), NR4A2 (NOT/Nurr1) and NR4A3 (MINOR/
NOR-1). All three family members are immediate early genes
induced by physiologic signals including growth factors,
hormones and inflammatory cytokines [13,14], and are shown
to promote cell proliferation, apoptosis and terminal
differentiation in a tissue dependent manner [15,16]. NR4A1
and NR4A3 are silenced in human acute myeloid leukemia
(AML), and abrogation of both genes in mice leads to rapid
postnatal development of AML [17,18]. NR4A2 is highly
expressed in several bladder cancer cell lines and activation of
the ligand-binding domain of NR4A2 was demonstrated to
induce apoptotic pathways and inhibit growth of bladder cancer
established in nude mice [19]. Contrary to the findings in
bladder cancer cells, NR4A2 is shown to promote growth of
colorectal cancer [20] and to transactivate osteopontin, a direct
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target of the Wnt/β-catenin pathway associated with colorectal
invasion and metastasis [21].
By microarray gene profiling we identified NR4A2 as a
gastrin responsive gene in the pancreatic adenocarcinoma cell
line AR42J [22]. In this study we examined the role of NR4A2
in the gastric adenocarcinoma cells. Gastrin transiently
regulates NR4A2 expression in AGS-GR cells. NR4A2 is known
to activate genes via cognate NBRE response elements, and
we show that NBRE reporter plasmid is activated upon gastrin
treatment. Ectopic expression of the transcriptional repressor
ICER (inducible cAMP early repressor) reduces gastrin induced
NR4A2 expression as well as transcriptional activation of the
NBRE reporter plasmid, indicating that ICER acts as a negative
regulator of gastrin induced NR4A2. We also show that gastrin
affects the NR4A2 nucleus-cytosol shuttling. We find that
ectopic expression of NR4A2 hampers gastrin induced
invasion, which indicates a role of NR4A2 in regulating invasive
properties of these cells. The molecular mechanisms likely to
be involved are gastrin induced changes in the NR4A2
nucleus-cytosolic shuttling and increased apoptosis.
Collectively, our study suggests a function of NR4A2
concurrent with a tumor suppressor role in gastric
adenocarcinoma cells.
Materials and Methods
Cells and reagents
Details concerning cultivation and treatment of pancreatic
adenocarcinoma AR42J cells for the genome –wide data sets
are described elsewhere [22] and in the legend to Figure 1.
AGS-GR cells (human gastric adenocarcinoma stable
transfected with CCK2R, gift from Prof. Andrea Varro,
University of Liverpool) [23] were grown in HAM’S F12
(GIBCO, Invitrogen, Carlsbad, CA) supplemented with 10%
FCS and 10 U/ml penicillin-streptomycin and 2µg/ml puromycin
(Sigma-Aldrich, St. Louis, MO). AR42J cells (rat pancreatic
acinar cell derived with endogenously expressed CCK2R;
American Type Culture Collection (ATCC), Rockville, MD) were
grown in DMEM (GIBCO, Invitrogen) with 4.5 g/l glucose, 15%
FCS, 1 mM sodiumpyruvate, 0.1 mg/ml L-glutamine, 10 U/ml
penicillin-streptomycin, and 1 µg/ml fungizone (all GIBCO,
Invitrogen). Gastrin (G-17) and cycloheximide (CHX) were
purchased from Sigma-Aldrich.
Expression plasmids
3xNBRE-Luc and pCMX-NR4A2 constructs were kindly
provided by Prof Thomas Perlmann, Karolinska Institute,
Sweden. pNR4A2-luc, containing the human NR4A2 promoter,
was a kind gift from Prof. Marc Montminy [24]. Sequence
verification of the plasmid identified -128 to +154 of the NR4A2
promoter, including the CRE element. pCONTROL-luc were
obtained from Panomics (CA, USA). NR4A2-EGFP was a kind
gift from Prof. Evely Murphy, University College Dublin, Ireland
[25]. pICER IIy and pICER I were constructed via homologous
recombination of ICER IIy or ICER I containing pDONR201
plasmid [26] and pEF5/FRT/V5-DEST (Invitrogen). Zfp36l1
(Berg36) entry clone (Berg36 ORF Express Shuttle Clone) was
ordered from GeneCopoeia (USA), and pZfp36l1-DEST was
constructed by homologous recombination with entry clone and
pDEST26 (Invitrogen). pCONTROL vectors were constructed
by restriction cutting in att sites in pEF5/FRT/V5-DEST with
EcoRV, and in pDEST26 with BsrGI, followed by re-ligation of
att sites, thereby removing the insert between the att sites.
pEF5/FRT/V5/GW-CAT was purchased from Invitrogen.
Transient transfection and gastrin treatment of cells
AGS-GR cells (5.0 x 105/well) were plated in 6-well plates and
transfected after 24 h with 2.5 µg plasmid and 12.5 µl
Metafectene PRO transfection reagent (Biontex Laboratories
GmbH, Martinsried, Germany) per well. 24 h after transfection,
cells were serum starved for 24 h before treatment with gastrin
as indicated in figure legends. Overexpression was verified by
qRT-PCR and Western blotting (Figure S2C/D).
siRNA
siRNA-ICER (Qiagen) was designed targeting sites within
human ICER: 5’- CAUUAUGGCUGUAACUGGATT-3’, and
annealed as described previously [26]. siNR4A2, siRNAs
siCONTROL#1, siCONTROL#2 and siGAPDH were obtained
from Ambion (Austin, TX). The siCONTROL-pool, ON-TARGET
plus Non-Targeting Pool, were obtained from Dharmacon
(Lafayette, CO). Downregulation of NR4A2 mRNA and protein
was verified by qPCR and Western blotting (Figure S2A/B).
Genome-wide gene time series expression analysis on
Illumina Expression Bead Chips
RNA amplifications and hybridization were performed at the
NTNU Genomics Core Facilely (GCF), as previously described
Selvik [22]. The data was normalised by loess adjustment
within time points and average quantile normalised between
time points. The data was analysed using the Limma (ver.
3.12.1) Bioconductor package [27]. The microarray data were
prepared according to minimum information about a microarray
experiment (MIAME) recommendations [28] and deposited in
the Array Express [29]. Detailed information about the
microarray designs and raw data files from the experiments are
accessible by use of these accession numbers: GSE32869,
and E-MTAB-1268 (Illumina platform).
Reporter gene assay
Cells (1.5 × 104/well) were plated in 96-well plates 24 h
before transfection. Transfection was carried out using
Metafectene™ PRO in 5:1 reagent to plasmid ratio, 84 ng
plasmid and phRL-null (Promega, Madison, WI) (1:50). The
transfection mixture was added to cells 24 h prior to gastrin
treatment. Cells were incubated for additional 4 or 6 h,
following lysis in 20 µl Promega lysis buffer (Madison, WI). For
co-transfections of plasmid and siRNA, 1.2 x 104 cells were
plated in 96-well plates, the next day transfected with siRNA to
a final concentration of 20 nM using the RNAiMAX reagent
(Invitrogen). After 24 h, cells were transfected with plasmid as
described above. Luciferase activity was measured using Dual
Luciferase kit (Promega), and Wallac 1420 Victor3 plate reader
(PerkinElmer, Boston, MA). In all experiments, firefly luciferase
activity was normalized to Renilla luciferase activity.
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Figure 1.  NR4A2 is induced by gastrin.  A: Temporal profiles of gastrin induced NR4A2 mRNA expression in pancreatic
adenocarcinoma cells (AR42J). The panels show data from three independent microarray time series experiments (accession
numbers E-MATAB-1268 and GSE32869); and the data points are presented as normalized log2-transformed signal intensities.
Experiment 1: mRNA expression level for untreated (green line) and sustained gastrin treated (blue line) cells. Experiment 2: mRNA
level in cells treated in a sustained mode (14 h of continuous presence of gastrin) and in a transient mode (gastrin was removed
after 1 h of treatment). Experiment 3: sustained gastrin treatment was measured in the presence (orange line) and absence (blue
line) of cycloheximide (CHX) at 6 different time points between 1 and 10 h. Green and grey lines show mRNA levels in untreated
and CHX treated control cells, respectively. All data points are mean of two biological replicates. Gastrin (10 nM) treated and
untreated control cells were grown in parallel and harvested (pool of 2-3 technical replicates) at several time points, as indicated in
the panels. In experiments with transient versus sustained gastrin treatment, the growth medium of untreated and gastrin treated
cells was removed 1 h after gastrin treatment; the cells were then washed with serum-free medium before fresh serum-free medium
with gastrin (sustained gastrin treated cells) or without gastrin (transiently gastrin treated or untreated cells) was added. In
experiments with the protein synthesis inhibitor cycloheximide (CHX), pre-treatments with CHX (10 µg/ml) were initiated 30 min
before gastrin (10 nM) was added. B: NR4A2 mRNA and protein level in gastrin treated (5 nM) AGS-GR cells. qRT-PCR data shown
are mean ± SEM of four biological replicas. Western blot image shows NR4A2 protein. Immunostaining for NR4A2 in normal gastric
oxyntic mucosa is shown in panels C-E: Strong NR4A2 immunoreactivity (C) in scattered single cells in normal gastric oxyntic
mucosa. Overlap between the cells showing strong NR4A2 immunoreactivity (D) and CgA immunoreactive neuroendocrine cells (E)
in serial sections (C at x400 magnification, E and F at x1000 magnification).
doi: 10.1371/journal.pone.0076234.g001
Gastrin Regulates NR4A2
PLOS ONE | www.plosone.org 3 September 2013 | Volume 8 | Issue 9 | e76234
cDNA synthesis and quantitative real-time PCR (qRT-
PCR)
Total RNA was extracted using RNeasy Mini Kit (Qiagen,
Germantown, MD). RNA integrity, quality and quantity were
evaluated by UV fiberoptic spectrophotometer (Nanodrop
Technologies, Rockland, DE). cDNA synthesis was performed
with 1 µg total RNA in a 20 µl reaction using the REVERSE-IT
1st Strand Synthesis Kit (ABgene, UK). After synthesis, cDNA
was diluted 1:2 with RNase-free water. qRT-PCR was
performed with 2.5 µl cDNA in 25 µl reaction mix using
ABsolute QPCR SYBR Green Mix (ABgene). Quantitative PCR
thermal cycling program: 15 min at 95°C, 40 thermal cycles of
15 s at 95°C, 20 s at 60°C and 40 s at 72°C. The primer
sequences used for qRT-PCR analyses are shown in Table S1.
PCR samples were run in triplicate and the average used for
further quantification. The relative expression ratios were
calculated using Pfaffl method [30], or the ∆∆Ct-method [31]
and individual expression values were normalized by
comparison with β-actin or GAPDH.
Western Blots
Cells were harvested in 100 µl RIPA (Thermo Scientific,
Rockford, USA). Blotting, washing and antibody incubation
were performed as previously described [32]. Binding of
secondary antibodies was visualized by the Super Signal West
Femto Maximum Sensitivity Substrate (Pierce, Thermo
Scientific, Rockford, IL) and Kodak Image Station 2000R
(Kodak, Pittsburgh, PA). The following antibodies were used:
anti-NR4A2 from Santa Cruz Biotechnology (Santa Cruz, CA)
and Abcam (Cambridge, UK); HRP-conjugated goat anti-rabbit
IgG (Cell Signaling, Beverly, MA), mouse monoclonal to beta
actin (Abcam), polyclonal HRP-conjugated goat anti-mouse
IgG (Dako, Glostrup, Denmark).
Immunohistochemistry
Sections for immunohistochemistry were taken from formalin
fixed paraffin embedded biopsies from our gastric carcinoma
biobank, containing both intestinal and diffuse type cancers
classified according to Laurén and normal gastric oxyntic
mucosa from patients with no evidence of gastric neoplasm
that underwent gastroscopy due to dyspeptic complaints
(approval Regional Committee for Medical Research Ethics No
018-02). Serial sections were mounted as mirrored. Before
immunostaining, the sections (4 µm) were deparaffinised,
rehydrated in graded solutions of ethanol and blocked of
endogenous peroxidase activity in 3% H2O2 for 10 min. Antigen
retrieval was achieved by boiling in citrate-buffer pH 6.0 for 15
min. NR4A2 was detected using monoclonal anti-NR4A2
(Abcam) (dilution 1:150) and incubation at 4°C overnight.
Neuroendocrine cells were detected using monoclonal anti-
chromogranin A (CgA) (Dako) (dilution 1:4000) and incubation
at 4°C overnight. The immunoreactions were visualized using
the rabbit/mouse EnVision-HRP and DAB+ kit (Dako).
Counterstaining was done with hematoxylin. Identical
concentration of an isotype equivalent antibody from non-
immunized animals (mouse IgG2a) (Dako) was used as
negative control.
Immunocytochemical staining and confocal
microscopy
Cells (2.0 x 104/well in 200 µl medium with 10% FBS) were
seeded on Lab-Tek™ Chambered Coverglass with 8 wells
(NUNC, Thermo Scientific, Rockford, IL) and transfected with
NR4A2-EGFP. After cultivation for 24 h, cells were serum
starved for 24 h and then treated with 5 nM gastrin for 0-60
min. Cells were fixed (4% paraformaldehyde in PBS) for 10
min, washed (PBS x 2) and permeabilized (ice-cold MeOH) for
10 min on ice and washed (PBS x 2). DNA was stained with
Draq-5 (1:1000) for 7 min, washed and stored at 4°C over night
before confocal microscopy. Confocal microscopy studies were
performed with a Zeiss Axiovert 100-M inverted microscope
equipped with an LSM 510 laser-scanning unit and a 1.4
numerical aperture ×63 Plan-Apochromat oil immersion
objective. To minimize photobleaching, laser power was
typically 20% under maximum, and the pinhole was set to 0.8–
1.2. Multitracking was used for dual color imaging. The Zeiss
LSM Image browser version 4 was used for acquisition, and
processing was completed using Adobe Illustrator CS5.
FRAP analyses
Fluorescence recovery after photobleaching (FRAP) analysis
was performed 24 h after transient transfection of AGS-GR cells
(0.2 x 106 cells/24mm Petri dish) with 2 µg NR4A2-EGFP and 6
µl Metafectene PRO. Gastrin (10nM) was added and the cells
left in the incubator for 20 min. Confocal microscopy was
performed with Zeiss LSM 510 Meta Live using a 63X/ 1.4 oil
DIC. The settings were configured to produce ten pre-bleach
images followed by bleaching with the 488nm line of a 50-mW
argon laser operating at 100% laser power. A fluorescence
image of single z sections with an optical splice of 0.7 µm was
used. The region of interest (ROI) used for bleaching was a
circle with 2.5 µm radius. We used a speed of 200 iterations
and the bleach time was 7.2 sec. Subsequent imaging
continued at the pre bleach speed until 80 sec was reached.
Fluorescence recovery was calculated using Sigma plot (Table
S2). The confocal imaging was performed at the Cellular &
Molecular Imaging Core Facility, Norwegian University of
Science and Technology.
Flow Cytometry
AGS-GR cells were plated in 6-well plates (3 x 105 cells/well).
The following day, cells were transfected with 2.5 µg NR4A2-
EGFP or control plasmid H3.1-GFP (kind gift from Prof. Terje
Johansen, University of Tromsø, Norway) using Metafectene
PRO. The next day cells were transferred to serum-free
medium. 48 h after transfection, cells were detached from
culture plates by Accutase (Sigma-Aldrich) treatment for further
processing. The extent of apoptosis was measured using
annexin V Alexa Fluor 647 conjugate (Invitrogen). The cells
were incubated with annexin V in binding buffer for 1 h, and
analyzed using an LSRII flow cytometer (BD Biosciences). The
cells were first gated for the absence or presence of EGFP-
fluorescence, and then the two populations were further
analyzed for apoptosis using annexin V Alexa Fluor 647. Cells
positive for annexin V were considered as apoptotic cells. Data
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were analyzed with FlowJo 7.6 software (Tree Star Inc.,
Ashland, Oregon, USA).
Migration assay
The xCELLigence® DP system (Roche Applied Science,
Germany) was used for measurement of migration. This
system utilizes specialized culture plates that contain gold
electrode arrays beneath the bottom of individual wells (CIM
plates). Cellular contact with the electrode surfaces increases
the impedance across the electrodes. This impedance value is
measured by the DP system and is reported in the
dimensionless unit of cell index. AGS-GR cells (3.5 x 105/well)
were seeded in 6-well plates. After 24 h the cells were
transfected with siRNA for 24 h, subsequently serum starved
for 24 h and then trypsinated, followed by reseeding (4.0 x 104
cells/well) in CIM-Plate 16 (Roche Applied Science). The plate
was placed on the Real-time xCELLigence Cell Analyzer
platform at 37°C to measure the migration index for the
duration of the experiments. 1 nM gastrin was used as
attractant. Cell migration was monitored every 15 min on a
RTCA DP instrument for 24 h. Data analysis was carried out
using RTCA Software 1.2 (Roche Applied Science).
Invasion assay
48 hours after transfection, invasion assay were performed in
24-well plates containing 8-µm pore Matrigel-coated inserts
according to the manufacturer’s instructions (Becton Dickinson,
Bedford, MA). AGS-GR cells (4.0 x 104 cells/well) in 0.5 ml
serum-free medium were plated in the insert with or without
addition of gastrin (0.3 nM) for 24 h. Cells invading the lower
surface of the membrane were stained with Reastain Quick-Diff
reagents (Reagena, Finland). The total cells in 5 fields per
membrane were counted, and the mean of 3 membranes per
experiment was calculated.
Statistical analysis
qRT-PCR data were statistically analyzed for significant
differences using REST (relative expression software tool) [33].
Reporter gene data which include several biological
experiments were analyzed using student two-tailed t-test
assuming unequal variance. Data were considered significant
at p<0.05, unless otherwise stated.
Results
NR4A2 expression is activated by gastrin
Genome-wide time series experiments identified NR4A2 as a
gastrin responsive gene in the pancreatic adenocarcinoma cell
line AR42J (Figure 1A). The mRNA expression was transient
with peak expression at 2 h, followed by decrease to baseline
after ~6-8 h of gastrin treatment (Figure 1A, panel1). Genome-
wide microarray time series analysis was also used to identify
genes that are affected by the duration of gastrin treatment in
adenocarcinoma cells [22]. As shown in Figure 1A, panel 2, the
expression of NR4A2 was higher and more prolonged in cells
treated in a sustained mode (gastrin present for 14 h) than in a
transient mode (gastrin removed after 1 h). To establish the
role of new protein synthesis in gastrin-mediated regulation of
NR4A2 transcript levels, we analyzed gastrin treated AR42J
cells in the presence of the translational inhibitor cycloheximide
(CHX). We found that the initial increase in transcript levels
occurs in the presence of CHX, demonstrating that NR4A2 is a
primary gastrin responsive gene (Figure 1A, panel 3). The
decline of NR4A2 transcript levels is abolished in the presence
of CHX, indicating that the transient nature of the gastrin
induced NR4A2 transcripts is dependent upon de novo protein
synthesis of a transcription inhibitor or of proteins that reduce
mRNA stability. Quantitative real-time PCR confirmed that
gastrin induced transient expression of NR4A2 mRNA, followed
by decrease to baseline after ~6 h of stimulation; and that
NR4A2 mRNA expression was sustained when protein
synthesis was inhibited by CHX (Figure S1).
We further examined the role of NR4A2 in gastrin induced
responses by employing the gastric adenocarcinoma cell line
AGS-GR Gastrin induced a ~8-fold induction of NR4A2 mRNA
in AGS-GR cells, followed by a rapid decrease to baseline after
~4 h of stimulation (Figure 1B). The NR4A2 protein expression
peaks at 2 h and displays a rapid decrease after 6 h, in
agreement with what is reported for other cells [34].
The expression pattern of endogenous NR4A2 was also
observed in vivo by immunohistochemistry. In normal gastric
oxyntic mucosa (n=4) there was strong immunoreactivity in
small, scattered single cells predominantly in the basal part and
situated between the other epithelial cells (Figure 1C). This
appearance is suggestive of neuroendocrine cells, and this was
confirmed by overlap in serial staining using antibody against
the neuroendocrine marker CgA (Figure 1D-E). NR4A2 was
most strongly expressed in cytoplasm of these cells, but also
nuclear staining was observed. In addition there was weaker
immunoreactivity in other epithelial cells of the mucosa (Figure
1C). Since the neuroendocrine cell population in oxyntic
mucosa is dominated by the ECL cell, which is known to
possess the CCK2R and to be the main gastrin responsive
epithelial cell [35], this supports our results showing that
NR4A2 expression is activated by gastrin.
Gastrin-induced NR4A2 activates NBRE promoter
elements
NR4A2 is known to activate target genes via the cognate
NBRE response element [36]. We wanted to determine
whether gastrin could affect NBRE regulated genes and thus
measured the NBRE reporter gene activity in gastrin treated
AGS-GR cells. Our results show that gastrin activates NBRE-
driven gene expression in a dose-dependent manner (Figure
2A). To verify that this gastrin response is mediated via
NR4A2, NBRE reporter gene activity was measured in gastrin
treated cells transfected with siRNA targeting NR4A2. We
demonstrate that siNR4A2 significantly reduces gastrin-
mediated activation of NBRE (Figure 2B), suggesting that
NR4A2-activated gene expression plays a role in gastrin
mediated responses.
The cellular effect of gastrin is transmitted via the Gαq/11
protein-coupled CCK2R and known to target a cascade of
intracellular mediators including protein kinase C (PKC),
phosphoinositide 3-kinase (PI 3-kinase), mitogen-activated
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protein kinases (MAPKs) and protein kinase A (PKA) [37-40].
Hence we examined the signaling pathways involved in gastrin-
mediated NR4A2 activation. Gastrin-induced NR4A2 gene
expression in AGS-GR cells was significantly reduced by
inhibitors of PKA or PKC, but not by the PI3K inhibitor (Figure
2C). This was some unexpected since gastrin mediated
signaling is reported to phosphorylate PKB/Akt [41]. However,
Western blot experiments demonstrated a constitutive
phosphorylation of PKB/Akt Ser-473 in AGS-GR cells (data not
shown), which likely explain why we did not observe any effect
of the LY294002 inhibitor. The NBRE reporter gene
experiments demonstrated that PKA and PKC signaling
pathways both participate in gastrin mediated NBRE
transcriptional activation (Figure 2D). Taken together, the
results indicate that gastrin induces NR4A2 gene expression
and NBRE target gene activation via PKA and PKC signaling
pathways.
Figure 2.  NR4A2 activates NBRE promoter elements.  A: Gastrin-induced NBRE-luc activation. Data represent one of two
biological replicas. B: The effect of NR4A2 siRNA on gastrin-induced NBRE activation. Data represent mean ± SEM of four
biological replicas (** p<0.01, * p=0.1). C-D: Effect of specific inhibitors of PKA (H-89, 10µM), PI3K (LY 294002, 10µM) or PKC (GF
109203x, 3.5µM) on (C) gastrin-induced NR4A2 gene expression and (D) gastrin-induced NBRE activation. Data represent one of
three biological replicas; mean ± SD of six technical replicas.
doi: 10.1371/journal.pone.0076234.g002
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NR4A2 is negatively regulated by gastrin-induced
proteins
We have previously shown that gastrin induces expression of
Inducible cAMP early repressor (ICER) [42], and that ICER
represses gastrin-induced genes with CRE promoter elements
[26,32]. The promoter region of the NR4A2 gene comprises
CRE regulatory elements [43,44]. Thus, it was of interest to
investigate whether ICER could modulate gastrin-induced
NR4A2 expression and with this constitute a gastrin induced
negative feedback mechanism. AGS-GR cells were transfected
with ICER I or ICER IIγ expression plasmids together with a
reporter plasmid for NR4A2 promoter activity; NR4A2-luc. Our
results show that ectopically expressed ICER significantly
reduces gastrin-induced NR4A2 gene expression (Figure 3A).
In addition, we find that ICER expression reduces NBRE
reporter gene activity by ~ 50% in gastrin treated cells (Figure
3B). ICER also affects NBRE activity in untreated cells. Our
results demonstrate that the role of ICER as a negative
feedback regulator of gastrin responses involves both
downregulation of NR4A2 gene expression and repression of
gastrin-induced NBRE-regulated genes.
NR4A2 possesses AU-rich elements (AREs) in its 3`-
untranslated region (3'-UTR)(http://rna.tbi.univie.ac.at/cgi-bin/
AREsite.cgi), and Zinc finger protein 36, C3H1 type-like 1
(Zfp36l1) is suggested to participate in the degradation of
short-lived, inducible mRNAs by binding to AREs [45,46]. We
found that gastrin induced Zfp36l1 expression in AR42J cells in
two independent microarray time series (E-MATAB-123 (cDNA
microarrays) and GSE32869 (Illumina)) and therefore
examined whether Zfp36l1 would influence the NR4A2 mRNA
levels. AGS-GR cells were transfected with Zfp36l1 expression
plasmid, and the amount of NR4A2 mRNA was assessed by
qRT-PCR. Gastrin-treated cells with ectopic expression of
Zfp36l1 exhibited significantly reduced levels of NR4A2
transcripts (Figure 3C). No effect of Zfp36l1 was observed in
the control experiments, by qRT-PCR measurement of the
expression of non-ARE genes like CyclinL1 (Figure 3D) and
Ywhag (data not shown). We conclude that NR4A2 transcript
levels are negatively regulated by at least two different gastrin
induced mechanisms: ICER represses the transcription, while
Zfp36l1 reduces NR4A2 mRNA levels by affecting its
degradation.
Gastrin facilitates change in the nucleus-cytosol
shuttling
Subcellular trafficking of nuclear receptors and the
subsequent protein interactions often affect the cellular
response. In addition to transactivation functions, NR4As are
reported to modulate the activity of other proteins through
subcellular translocation and protein-protein interactions
[47-51]. Thus it was of interest to establish a putative role of
gastrin in modifying the trafficking of NR4A2 proteins. AGS-GR
cells were transfected with NR4A2-EGFP and treated with
gastrin up to 60 min. We show that gastrin facilitates NR4A2
nucleus-cytosolic translocation (Figure 4A); increasing amount
of NR4A2-EGFP was located in the cytosol upon gastrin
treatment compared to the control where the better part of
NR4A2 is localized in the nucleus. To further explore the
protein shuttling, FRAP experiments were included.
Normalization curves were used to optimize the bleach
parameters. Based on a 2D diffusion model, we fitted the
individual FRAP curves using a non-linear regression analysis
(Sigmaplot) (Figure 4 B/C) [52,53]. We observed a significant
change in the diffusion time comparing gastrin treated versus
untreated cells, both in the nucleus and the cytosol (Figure 4D).
Our results show that NR4A2-EGFP resides for a longer time
(i.e. higher diffusion time) in cytosol compared to nucleus in
gastrin treated cells. The fact that NR4A2 is present for a
longer time period in cytosol compared to nucleus may affect
the cellular response. This is analogous to what has been
described for NR4A1, where mitochondrial localization is
shown to induce apoptosis [48]. Hence, we examined whether
apoptosis was induced in AGS-GR cells ectopically expressing
NR4A2, using flow cytometry and annexin V Alexa Fluor 647
labeling. We observed ~20% more apoptosis (p<0.05) in cells
overexpressing NR4A2 compared to controls (i.e. cells
transfected with the control plasmid H3.1-EGFP) (Figure 4E).
Treatment with gastrin did not influence the number of
apoptotic cells in this time period (data not shown).
NR4A2 suppresses gastrin-induced migration and
invasion
Little is known about the molecular mechanisms involved in
NR4A2 regulation, and conflicting data exists concerning its
role in cancer. However, NR4A2 has been characterized as a
putative tumor suppressor protein in gastric cancer, being
down-regulated both in primary gastric cancers and in
synchronous liver metastases [54]. Thus it was of interest to
examine whether NR4A2 would influence gastrin induced
migration and invasion in our gastric adenocarcinoma cells.
AGS-GR cells were transfected with siRNA targeting NR4A2
and migration assessed using real-time cell monitoring assay
(xCELLigence technology). As shown in Figure 5A, NR4A2
knock-down by itself resulted in a significant increase of
migration and gastrin treatment further enhanced this effect.
Next we determined the importance of NR4A2 in invasion, now
using AGS-GR cells with ectopically expressed NR4A2. We
show that ectopic expression of NR4A2 dramatically reduces
the number of invading cells as a consequence of gastrin
treatment (Figure 5B). Collectively, these results suggest that
high level of NR4A2 hampers the migratory potential of AGS-
GR cells.
NR4A2 protein is expressed in tumor cells in gastric
adenocarcinomas
To further substantiate the relevance of our findings in vivo,
we analyzed the protein expression of NR4A2 in a small
collection of gastric adenocarcinomas (intestinal n=3, diffuse
n=3) by immunohistochemistry (Figure 6A-F). Compared to
normal gastric oxyntic mucosa the expression pattern of
NR4A2 seemed to be changed in both cancer types. There
was not observed any strong staining specifically in single
cells. The pattern was rather dominated by a general
expression of NR4A2 in tumor cells, showing mixed nuclear or
cytoplasmic localization and variable intensities. Some weak
staining was also seen in mesenchymal cells. No differences
Gastrin Regulates NR4A2
PLOS ONE | www.plosone.org 7 September 2013 | Volume 8 | Issue 9 | e76234
regarding the type of gastric adenocarcinoma or nucleus
versus cytosolic localization could be read from this small
cohort. Our findings are in accordance with the OncoMine
database (https://www.oncomine.org), where NR4A2 gene
expression is shown to vary both within and among subtypes of
gastric adenocarcinomas; being both higher and lower
expressed compared to normal controls.
Discussion
In the present study we address the function of the orphan
nuclear receptor NR4A2 in gastrin regulated responses. Our
principal findings are that gastrin regulates NR4A2 expression
and activity in gastric adenocarcinoma AGS-GR cells. The
regulation involves gastrin induced nucleus-cytosolic shuttling
of NR4A2. We find that sustained expression of NR4A2 inhibits
gastrin induced invasiveness, which is congruent with a tumor
Figure 3.  Negative regulation of gastrin-induced NR4A2 expression.  A: AGS-GR cells transfected with NR4A2-luc and ICER
expression plasmids or empty vector. Cells were treated with gastrin for 6 h prior to measurement of NR4A2 activity. Data shown
represent mean ± SEM of five biological replicas (** p<0.03, * p = 0.06). B: AGS-GR cells transfected with NBRE-luc and ICER
expression plasmid or empty vector and treated with gastrin for 4 h prior to measurement of NBRE activity. Data shown represent
mean ± SEM of four biological replicas (** p<0.03). C: AGS-GR cells were transfected with pZfp36l1 expression plasmid or empty
vector and treated with gastrin (5 nM) NR4A2 mRNA expression was measured by qRT-PCR. Data shown represent one of three
biological replicas; mean ± SD of three technical replicas is shown. D: Cyclin L1 represents one of three control genes examined.
doi: 10.1371/journal.pone.0076234.g003
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Figure 4.  Gastrin treatment influences nucleus-cytosolic shuttling of NR4A2.  A: Intracellular localization of NR4A2 protein in
response to gastrin treatment. AGS-GR cells transfected with pNR4A2-EGFP. B: Images of gastrin treated (10 nM) AGS-GR cells
expressing pNR4A2-EGFP before, during and after bleaching of a nucleus area for 7.5 sec. The circle indicates the area of the
bleach spot. C: Normalized FRAP curve for the cytosol of gastrin treated AGS-GR cells. D: Diffusion time in untreated and gastrin
treated nucleus and cytosol. E: To determine cell viability, cells were transfected with pNR4A2-EGFP or a control plasmid (pH3.1-
EGFP). After 48 h AGS-GR cells were detached by Accutase treatment, labeled with annexin V Alexa Fluor 647 and analyzed by
flow cytometry. Annexin-V positive cells were considered as apoptotic. Results are shown as % apoptotic cells of the total number of
counted EGFP positive or EGFP negative cells. Data are representative of three biological replicas; mean ± SD of three technical
replicas is shown.
doi: 10.1371/journal.pone.0076234.g004
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suppressor function of NR4A2 in AGS-GR cells. This is in
contrast to a transient expression of NR4A2 which does not
affect gastrin induced invasiveness or proliferation [55,56],
indicating that a threshold level of NR4A2 is of vital importance
for the cellular decision towards migration/invasion. The gastrin
induced regulation of NR4A2 was further substantiated in vivo
 by strong NR4A2 expression in the gastrin responsive
neuroendocrine ECL cells in normal gastric oxyntic mucosa.
Gastrin is known to promote proliferation, migration and
invasion of AGS-GR cells [55-57]. Thus, the transient induction
of NR4A2 by gastrin may play a role in the gastrin induced
migration and invasion of these cells. A putative cross talk
Figure 5.  NR4A2 suppresses gastrin-induced migration and invasion.  A: Real-time cell migration monitored (0-24 h) in AGS-
GR cells transfected with siNR4A2 or siCtr, with or without gastrin treatment (10 nM). Results show one representative of three
biological replicas; mean ±SD of three technical replicas. B: Invasion assay with AGS-GR cells transfected with pCMX-NR4A2 or
pCMX (control) was performed in 24-well plates containing 8-µm pore Matrigel-coated inserts (with or without 0.3 nM gastrin). Cells
invading the lower surface of the membrane were stained with Reastain Quick-Diff reagents and total numbers of cells in 5 fields per
membrane were counted. The mean of three independent experiments is shown.
doi: 10.1371/journal.pone.0076234.g005
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between NR4A2 and the Wnt signaling pathway has been
suggested [49], involving NR4A2 cytoplasmic translocation and
de-repression of transcription upon beta-catenin treatment.
However, in contrast to transient induction of NR4A2, we show
that sustained (i.e. ectopic) expression of NR4A2 increases
apoptosis and hampers the invasiveness of AGS-GR cells. This
may suggest that some threshold effect of NR4A2 exists when
it comes to its influence on apoptosis of gastric
adenocarcinoma cells, corresponding to what is found in the
breast cancer study by Llopis et al [58]. Low expression level of
NR4A2 in AGS-GR cells is supportive with migration and
invasion (untreated AGS-GR cells show low levels of NR4A2
proteins, Figure 1B), while high or sustained level of NR4A2
reduces the invasiveness of the cells through distinct
mechanisms, which also involves apoptosis. We speculate that
the increased apoptosis of AGS-GR cells might be due to
NR4A2 mediated modulation of proteins through protein-
protein interactions in cytosol, and/or NR4A2 localization/
association with mitochondria analogous to what has been
described for NR4A1 [48]. Interestingly, nucleus to cytosol
trafficking of NR4A1 is suggested to be the molecular switch
that dislodges the Bcl-2 BH4 domain, exposing its BH3 domain,
which in turn blocks the activity of anti-apoptotic Bcl-X(L) [48].
Whether NR4A2 is involved in a corresponding mechanism in
gastric adenocarcinoma cells is not known. Taken together, we
advocate that high and sustained level of NR4A2 in AGS-GR
cells reduces migration/invasion partly by promoting apoptosis,
while transient expression of NR4A2 does not seems to affect
such mechanisms.
NR4A2 is characterized as a hub gene [54], a term initially
used to describe central proteins of transcriptional networks
[59]. Hub proteins may regulate quite different biological
processes since they interact with several proteins and
represent important regulatory nodes in biological networks. In
a recent study investigating the expression of NR4A2 in breast
cancer, the authors concluded that NR4A2 expression in breast
is commensurate with a normal and terminally differentiated
epithelial phenotype, whereas silencing or dysregulation of
NR4A2 probably plays a role in oncogenic transformation of
breast epithelial cells [58]. In accordance with this, we also
observed changed NR4A2 expression in gastric
adenocarcinomas, seemingly being dominated by a general
expression in tumor cells compared to the mainly strong
NR4A2 expression in the gastrin responsive neuroendocrine
ECL cells in normal mucosa. In tumor cells the expression
showed variable intensities which is in agreement with our own
data and the data from OncoMine (https://www.oncomine.org).
Our finding in normal mucosa is in contrast to Chang et al [54]
Figure 6.  Immunostaining of NR4A2 in gastric adenocarcinoma.  A-B: NR4A2 immunoreactivity in normal oxyntic mucosa
showing strong intensity in scattered single cells (neuroendocrine cells) and weaker staining intensity in the other epithelial cells. C-
F: NR4A2 immunoreactivity in gastric adenocarcinomas of intestinal (C-D) and diffuse (E-F) type, showing a general staining in
tumor cells with mixed nuclear or cytoplasmic localization and variable intensities. (A, C, E at x200 magnification, with boxes
representing B, D and F at x400 magnification).
doi: 10.1371/journal.pone.0076234.g006
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showing primarily mesenchymal expression of NR4A2 in
normal mucosa, with a change to stronger epithelial expression
in primary gastric cancers and a further nearly loss of
expression in paired liver metastasis. In addition to the
dichotomous behavior of NR4A2, differences in antibody
specificities could also explain such differences. In a study from
Holla et al [20] intestinal epithelium from Apc-/+ mouse
adenomas and sporadic colorectal carcinomas exhibit
increased NR4A2 expression relative to matched normal
mucosa. However, the mechanisms elucidated in this study
indicated that NR4A2 was important for PGE2-mediated
regulation of apoptosis, and thus is likely to mirror mechanisms
such as inflammatory signaling pathways, which are known to
play a prominent role in colorectal cancer. Taken together, the
partly conflicting results published so far, probably reflect both
tissue- and cell specific differences in addition to a biphasic
role of NR4A2.
In this study we throw light on the dichotomous role of
NR4A2 in cancer. We conclude that gastrin induced NR4A2
expression and transactivation play an important role in gastric
adenocarcinoma cells. The amount of NR4A2 protein and/or
the lack of negative feedback regulation may switch the cellular
response. A better understanding of gastrin–NR4A2 regulated
processes may reveal new strategies to treatment of gastric
adenocarcinomas.
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Figure S1.  NR4A2 mRNA expression in gastrin treated
AR42J cells measured by qRT-PCR. The cells were pre-
treated with the protein synthesis inhibitor cycloheximide (CHX)
(10 µg/ml) for 30 min before gastrin (10 nM) was added. Data
represent one of three biological replicas; mean ± SD of three
technical replicas.
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expression plasmid. A: qRT-PCR data showing NR4A2
mRNA expression in gastrin treated AGS-GR cells transfected
with siNR4A2 or siCtr. B: Western blot showing NR4A2 protein
in gastrin treated AGS-GR cells transfected with siNR4A2 or
siCtr. C: qRT-PCR showing NR4A2 mRNA expression in
gastrin treated AGS-GR cells transfected with pCMX-NR4A2 or
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treated AGS-GR cells transfected with pCMX-NR4A2 or pCMX.
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